DSS Raises $1M in Public Offering

The capital raise will bolster DSS’s growth across packaging, biotech, lending, and investment sectors.

February 06, 2026

Capital Raised to Support Core Operations

DSS, Inc. has secured $1 million in fresh capital through an underwritten public offering, reinforcing its ability to fund operations across its portfolio of businesses. The offering consisted of 900,000 shares priced at $1.00 each. The company also gave the underwriter, Aegis Capital Corp., an option to purchase up to 135,000 additional shares to cover over-allotments.

Proceeds from the raise are earmarked for general corporate purposes, with a focus on maintaining flexibility and supporting day-to-day operations. That includes working capital needs across DSS’s business units—from product packaging and biotechnology to commercial lending and investment management.

Fueling a Growth-Focused Strategy

DSS follows a growth strategy centered on building high-potential subsidiaries. These businesses are structured to scale, with long-term value realized through IPOs and public listings. This latest raise gives DSS more room to pursue those goals while staying responsive to operational demands.

The deal was conducted under a shelf registration statement declared effective by the SEC in late 2024. Legal support came from Sichenzia Ross Ference Carmel LLP for DSS and Kaufman & Canoles, P.C. for Aegis Capital Corp.

DSS continues to position itself for expansion, and this capital provides a near-term boost to keep that momentum going.